Revive Therapeutics Ltd. (RVV.CN)
CAD 0.02
(-25.0%)
CAD 0.02
(-25.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -797.85 Thousand CAD | 57.28% |
| 2022 | -1.86 Million CAD | 47.94% |
| 2021 | -3.58 Million CAD | 77.83% |
| 2020 | -16.18 Million CAD | -1667.51% |
| 2019 | -915.62 Thousand CAD | -92.67% |
| 2018 | -475.23 Thousand CAD | 55.19% |
| 2017 | -1.06 Million CAD | 40.04% |
| 2016 | -1.76 Million CAD | -32.66% |
| 2015 | -1.33 Million CAD | 46.5% |
| 2014 | -2.49 Million CAD | -109.61% |
| 2013 | -1.18 Million CAD | -1240.38% |
| 2012 | -88.7 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -662.36 Thousand CAD | 52.79% |
| 2023 Q4 | -797.85 Thousand CAD | 23.13% |
| 2023 Q1 | -1.4 Million CAD | 29.06% |
| 2023 Q3 | -1.03 Million CAD | -56.69% |
| 2022 Q2 | -433.78 Thousand CAD | 66.21% |
| 2022 Q3 | -2.51 Million CAD | -480.18% |
| 2022 FY | -1.86 Million CAD | 47.94% |
| 2022 Q4 | -1.97 Million CAD | 21.42% |
| 2022 Q1 | -1.28 Million CAD | 64.22% |
| 2021 Q4 | -3.58 Million CAD | 27.3% |
| 2021 FY | -3.58 Million CAD | 77.83% |
| 2021 Q1 | -14.42 Million CAD | 10.89% |
| 2021 Q2 | -8.92 Million CAD | 38.12% |
| 2021 Q3 | -4.93 Million CAD | 44.7% |
| 2020 Q2 | -3.94 Million CAD | -33.86% |
| 2020 Q3 | -18.6 Million CAD | -371.71% |
| 2020 Q4 | -16.18 Million CAD | 13.03% |
| 2020 FY | -16.18 Million CAD | -1667.51% |
| 2020 Q1 | -2.94 Million CAD | -221.88% |
| 2019 Q1 | 201.91 Thousand CAD | 142.49% |
| 2019 Q4 | -915.62 Thousand CAD | -654.36% |
| 2019 Q3 | -121.37 Thousand CAD | -129.94% |
| 2019 FY | -915.62 Thousand CAD | -92.67% |
| 2019 Q2 | 405.44 Thousand CAD | 100.8% |
| 2018 Q3 | -829.84 Thousand CAD | -72.37% |
| 2018 Q1 | -766.52 Thousand CAD | 27.72% |
| 2018 FY | -475.23 Thousand CAD | 55.19% |
| 2018 Q4 | -475.23 Thousand CAD | 42.73% |
| 2018 Q2 | -481.43 Thousand CAD | 37.19% |
| 2017 Q2 | -1.4 Million CAD | -0.16% |
| 2017 FY | -1.06 Million CAD | 40.04% |
| 2017 Q3 | -1.28 Million CAD | 8.63% |
| 2017 Q4 | -1.06 Million CAD | 17.61% |
| 2017 Q1 | -1.4 Million CAD | 20.48% |
| 2016 FY | -1.76 Million CAD | -32.66% |
| 2016 Q3 | -2.22 Million CAD | -30.3% |
| 2016 Q4 | -1.76 Million CAD | 20.44% |
| 2016 Q2 | -1.7 Million CAD | 18.77% |
| 2016 Q1 | -2.1 Million CAD | -57.54% |
| 2015 Q1 | -1.79 Million CAD | 28.15% |
| 2015 Q4 | -1.33 Million CAD | -73.56% |
| 2015 FY | -1.33 Million CAD | 46.5% |
| 2015 Q3 | -768.17 Thousand CAD | 24.83% |
| 2015 Q2 | -1.02 Million CAD | 42.93% |
| 2014 Q4 | -2.49 Million CAD | 11.27% |
| 2014 Q2 | -3.21 Million CAD | -227.07% |
| 2014 Q1 | -982.36 Thousand CAD | 17.37% |
| 2014 Q3 | -2.8 Million CAD | 12.58% |
| 2014 FY | -2.49 Million CAD | -109.61% |
| 2013 Q4 | -1.18 Million CAD | 20.12% |
| 2013 FY | -1.18 Million CAD | -1240.38% |
| 2013 Q2 | -1.84 Million CAD | -512.34% |
| 2013 Q3 | -1.48 Million CAD | 19.36% |
| 2013 Q1 | -301.39 Thousand CAD | -293.22% |
| 2012 FY | -88.7 Thousand CAD | 0.0% |
| 2012 Q4 | -76.64 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aion Therapeutic Inc. | 826.13 Thousand CAD | 196.576% |
| Ayurcann Holdings Corp. | 69.97 Thousand CAD | 1240.128% |
| Blueberries Medical Corp. | -805.35 Thousand CAD | 0.932% |
| The BC Bud Corporation | 225.15 Thousand CAD | 454.359% |
| BioNxt Solutions Inc. | 4.53 Million CAD | 117.611% |
| CordovaCann Corp. | 6.13 Million CAD | 113.013% |
| Christina Lake Cannabis Corp. | 4.62 Million CAD | 117.239% |
| Captor Capital Corp. | -5.41 Million CAD | 85.254% |
| City View Green Holdings Inc. | 1.49 Million CAD | 153.253% |
| 1CM Inc. | 3.31 Million CAD | 124.068% |
| Global Hemp Group Inc. | 3.55 Million CAD | 122.461% |
| Greenway Greenhouse Cannabis Corporation | 14.48 Million CAD | 105.506% |
| IM Cannabis Corp. | 11.96 Million CAD | 106.666% |
| Lobe Sciences Ltd. | 192.35 Thousand CAD | 514.791% |
| Maple Leaf Green World Inc. | 2.47 Million CAD | 132.251% |
| Mountain Valley MD Holdings Inc. | -5.91 Million CAD | 86.511% |
| Nextleaf Solutions Ltd. | -449.15 Thousand CAD | -77.634% |
| Ovation Science Inc. | 143.76 Thousand CAD | 654.964% |
| Pharmadrug Inc. | 1.2 Million CAD | 166.119% |
| Captiva Verde Wellness Corp. | 186.26 Thousand CAD | 528.353% |
| RAMM Pharma Corp. | -4.71 Million CAD | 83.067% |
| RIV Capital Inc. | -101.38 Million CAD | 99.213% |
| Red White & Bloom Brands Inc. | 259.87 Million CAD | 100.307% |
| SLANG Worldwide Inc. | 20.83 Million CAD | 103.83% |
| 1933 Industries Inc. | 16.47 Million CAD | 104.842% |
| Red Light Holland Corp. | -13.56 Million CAD | 94.117% |
| Top Strike Resources Corp. | 13.24 Million CAD | 106.022% |
| Xebra Brands Ltd. | -102.41 Thousand CAD | -679.013% |
| Adastra Holdings Ltd. | 2.2 Million CAD | 136.195% |